USD 133.97
(-5.82%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.57 Billion USD | -2.83% |
2022 | 1.62 Billion USD | 4405.45% |
2021 | 36.03 Million USD | -16.98% |
2020 | 43.4 Million USD | 50.22% |
2019 | 28.89 Million USD | 368.7% |
2018 | -10.75 Million USD | -260.6% |
2017 | 6.69 Million USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
1996 | - USD | 0.0% |
1995 | - USD | 0.0% |
1994 | - USD | 0.0% |
1993 | - USD | 0.0% |
1992 | - USD | 0.0% |
1991 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 1.61 Billion USD | -0.73% |
2024 Q2 | 1.55 Billion USD | -0.73% |
2023 FY | 1.57 Billion USD | -2.83% |
2023 Q4 | 1.57 Billion USD | -0.72% |
2023 Q3 | 1.58 Billion USD | -0.72% |
2023 Q2 | 1.6 Billion USD | -0.71% |
2023 Q1 | 1.61 Billion USD | -0.71% |
2022 Q4 | 1.62 Billion USD | -4.18% |
2022 Q3 | 1.69 Billion USD | -0.69% |
2022 Q1 | 1.71 Billion USD | 4665.76% |
2022 FY | 1.62 Billion USD | 4405.45% |
2022 Q2 | 1.7 Billion USD | -0.65% |
2021 FY | 36.03 Million USD | -16.98% |
2021 Q2 | 39.92 Million USD | -4.77% |
2021 Q3 | 37.6 Million USD | -5.81% |
2021 Q4 | 36.03 Million USD | -4.15% |
2021 Q1 | 41.91 Million USD | -3.43% |
2020 Q3 | 44.78 Million USD | -3.85% |
2020 Q1 | 45.76 Million USD | 58.39% |
2020 Q2 | 46.57 Million USD | 1.77% |
2020 FY | 43.4 Million USD | 50.22% |
2020 Q4 | 43.4 Million USD | -3.08% |
2019 Q3 | 29.79 Million USD | -1.08% |
2019 Q4 | 28.89 Million USD | -3.0% |
2019 Q1 | 30.64 Million USD | 384.93% |
2019 Q2 | 30.11 Million USD | -1.71% |
2019 FY | 28.89 Million USD | 368.7% |
2018 FY | -10.75 Million USD | -260.6% |
2018 Q1 | 6.81 Million USD | 1.84% |
2018 Q3 | 1.93 Million USD | 0.0% |
2018 Q2 | - USD | -100.0% |
2018 Q4 | -10.75 Million USD | -655.48% |
2017 Q3 | 75 Million USD | 0.0% |
2017 Q2 | 75 Million USD | 0.0% |
2017 FY | 6.69 Million USD | 0.0% |
2017 Q4 | 6.69 Million USD | -91.07% |
2017 Q1 | 75 Million USD | 50235.57% |
2016 Q4 | 149 Thousand USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | -100.0% |
2016 Q2 | - USD | 0.0% |
2015 Q4 | 116 Thousand USD | 0.0% |
2015 Q1 | - USD | 100.0% |
2015 Q2 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | -1.37 Million USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 100.0% |
2014 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 100.0% |
2013 Q4 | -3.63 Million USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | -5.24 Million USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 100.0% |
2011 Q4 | -7.14 Million USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q1 | - USD | 100.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2010 Q4 | -8.02 Million USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 100.0% |
2010 FY | - USD | 0.0% |
2009 Q4 | -5.69 Million USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q1 | - USD | 100.0% |
2007 Q2 | - USD | 0.0% |
2007 Q4 | -4.32 Million USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1998 FY | - USD | 0.0% |
1998 Q1 | - USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1997 Q1 | - USD | 0.0% |
1997 Q4 | - USD | 0.0% |
1997 Q2 | - USD | 0.0% |
1997 FY | - USD | 0.0% |
1996 Q1 | - USD | 0.0% |
1996 Q2 | - USD | 0.0% |
1996 Q3 | - USD | 0.0% |
1996 FY | - USD | 0.0% |
1996 Q4 | - USD | 0.0% |
1995 Q2 | - USD | 0.0% |
1995 Q1 | - USD | 0.0% |
1995 FY | - USD | 0.0% |
1995 Q4 | - USD | 0.0% |
1995 Q3 | - USD | 0.0% |
1994 Q2 | - USD | 0.0% |
1994 FY | - USD | 0.0% |
1994 Q1 | - USD | 0.0% |
1994 Q3 | - USD | 0.0% |
1994 Q4 | - USD | 0.0% |
1993 Q1 | - USD | 0.0% |
1993 Q2 | - USD | 0.0% |
1993 Q3 | - USD | 0.0% |
1993 Q4 | - USD | 0.0% |
1993 FY | - USD | 0.0% |
1992 FY | - USD | 0.0% |
1992 Q1 | - USD | 0.0% |
1992 Q4 | - USD | 0.0% |
1992 Q2 | - USD | 0.0% |
1992 Q3 | - USD | 0.0% |
1991 Q4 | - USD | 0.0% |
1991 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 75.25 Million USD | -1996.593% |
AngioDynamics, Inc. | 3.93 Million USD | -39955.09% |
AtriCure, Inc. | 60.59 Million USD | -2503.882% |
Avinger, Inc. | - USD | -Infinity% |
Azenta, Inc. | 60.43 Million USD | -2510.646% |
BioLife Solutions, Inc. | 18.31 Million USD | -8516.515% |
The Cooper Companies, Inc. | 2.52 Billion USD | 37.484% |
Daxor Corporation | 755.65 Thousand USD | -208693.914% |
Ekso Bionics Holdings, Inc. | 4.83 Million USD | -32552.525% |
Femasys Inc. | 4.25 Million USD | -36952.693% |
GlucoTrack, Inc. | 196 Thousand USD | -804884.694% |
Harvard Bioscience, Inc. | 30.7 Million USD | -5038.646% |
Hologic, Inc. | 2.49 Billion USD | 36.816% |
Intuitive Surgical, Inc. | -82.1 Million USD | 2021.766% |
KORU Medical Systems, Inc. | 3.65 Million USD | -43091.986% |
LeMaitre Vascular, Inc. | 16.62 Million USD | -9390.917% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 871.7 Million USD | -80.999% |
Microbot Medical Inc. | 40 Thousand USD | -3944325.0% |
Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -34359002.787% |
Merit Medical Systems, Inc. | 823.01 Million USD | -91.707% |
Nephros, Inc. | 1.39 Million USD | -113408.633% |
NovoCure Limited | 596.24 Million USD | -164.619% |
NEXGEL, Inc. | 513 Thousand USD | -307457.505% |
NEXGEL, Inc. | 513 Thousand USD | -307457.505% |
Singular Genomics Systems, Inc. | 67.52 Million USD | -2236.606% |
OraSure Technologies, Inc. | 11.38 Million USD | -13754.672% |
Pro-Dex, Inc. | 7.53 Million USD | -20836.438% |
Pulse Biosciences, Inc. | 8.08 Million USD | -19412.367% |
Predictive Oncology Inc. | 2.18 Million USD | -71977.896% |
Precision Optics Corporation, Inc. | 1.93 Million USD | -81313.541% |
QuidelOrtho Corporation | 2.27 Billion USD | 30.629% |
Repligen Corporation | 510.14 Million USD | -209.28% |
Sanara MedTech Inc. | 9.11 Million USD | -17213.165% |
STAAR Surgical Company | 31.46 Million USD | -4914.046% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 295 Thousand USD | -534737.288% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 12.151% |
Jin Medical International Ltd. | - USD | -Infinity% |